Who
Nishant C. Saxena
Chief Business Officer
Company insider
Files Form 4 as: Chief Business Officer, Corbus Pharmaceuticals Holdings.
In numbers
- Trades disclosed
- 10
- Buys
- 3
- Sells
- 0
- Bought
- $252K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 21 May 2026
- Last trade
- 11 Aug 2026
- Last filed
- 12 Aug 2026
Companies traded
Activity over time
1 Jun – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Aug 2026filed 12 Aug 2026 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Bought | $25K2,600 at $9.63 | filing |
| 11 Aug 2026filed 12 Aug 2026 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Bought | $25K2,600 at $9.63 | filing |
| 3 Jun 2026filed 3 Jun 2026 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Bought | $68K9,000 at $7.58 | filing |
| 3 Jun 2026filed 3 Jun 2026 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Bought | $68K9,000 at $7.58 | filing |
| 2 Jun 2026filed 3 Jun 2026 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Bought | $33K4,500 at $7.33 | filing |
| 2 Jun 2026filed 3 Jun 2026 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Bought | $33K4,500 at $7.33 | filing |
| 21 May 2026filed 22 May 2026 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Code A | —58,300 at $0.00 | filing |
| 21 May 2026filed 22 May 2026 | CRBP Corbus Pharmaceuticals Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —192,300 at $0.00 | filing |
| 21 May 2026filed 22 May 2026 | CRBP Corbus Pharmaceuticals Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —192,300 at $0.00 | filing |
| 21 May 2026filed 22 May 2026 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Code A | —58,300 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.